Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
30,284,111
-
Total 13F shares
-
13,786,856
-
Share change
-
-317,036
-
Total reported value
-
$544,829,923
-
Price per share
-
$39.56
-
Number of holders
-
86
-
Value change
-
-$17,082,591
-
Number of buys
-
41
-
Number of sells
-
33
Institutional Holders of Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) as of Q3 2021
As of 30 Sep 2021,
Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,786,856 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Nantahala Capital Management, LLC, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, FRANKLIN RESOURCES INC, Opaleye Management Inc., and Clal Insurance Enterprises Holdings Ltd.
This page lists
87
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.